DZ Bank Aktienanleihe MRK 22.11.2.../ DE000DJ6QK02 /
2024-05-30 8:08:47 AM | Chg.-0.06 | Bid1:19:33 PM | Ask1:19:33 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
100.39EUR | -0.06% | 100.25 Bid Size: 200,000 |
100.35 Ask Size: 200,000 |
MERCK KGAA O.N. | 150.00 EUR | 2024-11-22 | Call |
GlobeNewswire
1:00 PM
LAVA Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
05-29
Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio fo...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA